Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

The Molecular Study of Antibiotic Resistance to Quinolones in Salmonella enterica Strains Isolated in Tehran, Iran.

Malehmir S, Ranjbar R, Harzandi N.

Open Microbiol J. 2017 Sep 21;11:189-194. doi: 10.2174/1874285801711010189. eCollection 2017.

2.

Estimated Incidence of Antimicrobial Drug-Resistant Nontyphoidal Salmonella Infections, United States, 2004-2012.

Medalla F, Gu W, Mahon BE, Judd M, Folster J, Griffin PM, Hoekstra RM.

Emerg Infect Dis. 2016 Jan;23(1):29-37. doi: 10.3201/eid2301.160771.

3.

Re-emergence of the susceptibility of the Salmonella spp. isolated from blood samples to conventional first line antibiotics.

Shrestha KL, Pant ND, Bhandari R, Khatri S, Shrestha B, Lekhak B.

Antimicrob Resist Infect Control. 2016 May 25;5:22. doi: 10.1186/s13756-016-0121-8. eCollection 2016.

4.

Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected].

Fang FC.

J Clin Microbiol. 2015 Nov;53(11):3401-4. doi: 10.1128/JCM.02270-15. Epub 2015 Aug 26. Erratum in: J Clin Microbiol. 2016 Jan;54(1):245.

5.

Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.

Skov R, Matuschek E, Sjölund-Karlsson M, Åhman J, Petersen A, Stegger M, Torpdahl M, Kahlmeter G.

J Clin Microbiol. 2015 Nov;53(11):3411-7. doi: 10.1128/JCM.01287-15. Epub 2015 Aug 19.

6.

Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.

Khan WA, Saha D, Ahmed S, Salam MA, Bennish ML.

PLoS One. 2015 Aug 13;10(8):e0134921. doi: 10.1371/journal.pone.0134921. eCollection 2015.

7.

Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM.

Clin Microbiol Rev. 2015 Oct;28(4):901-37. doi: 10.1128/CMR.00002-15. Review.

8.

Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002-2013) and molecular characterization of quinolone resistant isolates.

Nüesch-Inderbinen M, Abgottspon H, Sägesser G, Cernela N, Stephan R.

BMC Infect Dis. 2015 May 12;15:212. doi: 10.1186/s12879-015-0948-2.

9.

Typhoid fever acquired in the United States, 1999-2010: epidemiology, microbiology, and use of a space-time scan statistic for outbreak detection.

Imanishi M, Newton AE, Vieira AR, Gonzalez-Aviles G, Kendall Scott ME, Manikonda K, Maxwell TN, Halpin JL, Freeman MM, Medalla F, Ayers TL, Derado G, Mahon BE, Mintz ED.

Epidemiol Infect. 2015 Aug;143(11):2343-54. doi: 10.1017/S0950268814003021. Epub 2014 Nov 27.

10.

Plasmid-mediated quinolone resistance (PMQR) and mutations in the topoisomerase genes of Salmonella enterica strains from Brazil.

Ferrari R, Galiana A, Cremades R, Rodríguez JC, Magnani M, Tognim MC, Oliveira TC, Royo G.

Braz J Microbiol. 2013 Oct 30;44(2):651-6. doi: 10.1590/S1517-83822013000200046. eCollection 2013.

11.

Comparative pharmacokinetics of levofloxacin in healthy volunteers and in patients suffering from typhoid Fever.

Usman M, Ashraf M, Khokhar MI, Ashiq B, Masood MI, Afzal S, Omer O, Ali M, Qadir MI.

Iran J Pharm Res. 2013 Winter;12(1):147-54.

12.

Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo.

Gnanadhas DP, Ben Thomas M, Thomas R, Raichur AM, Chakravortty D.

Antimicrob Agents Chemother. 2013 Oct;57(10):4945-55. doi: 10.1128/AAC.00152-13. Epub 2013 Jul 22.

13.

Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.

Choudhary A, Gopalakrishnan R, Nambi PS, Ramasubramanian V, Ghafur KA, Thirunarayan MA.

Indian J Med Res. 2013 Apr;137(4):800-2.

14.

Use of population-based surveillance to define the high incidence of shigellosis in an urban slum in Nairobi, Kenya.

Njuguna HN, Cosmas L, Williamson J, Nyachieo D, Olack B, Ochieng JB, Wamola N, Oundo JO, Feikin DR, Mintz ED, Breiman RF.

PLoS One. 2013;8(3):e58437. doi: 10.1371/journal.pone.0058437. Epub 2013 Mar 7. Erratum in: PLoS One. 2014;9(8):e105031.

15.

Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa.

Breiman RF, Cosmas L, Njuguna H, Audi A, Olack B, Ochieng JB, Wamola N, Bigogo GM, Awiti G, Tabu CW, Burke H, Williamson J, Oundo JO, Mintz ED, Feikin DR.

PLoS One. 2012;7(1):e29119. doi: 10.1371/journal.pone.0029119. Epub 2012 Jan 19.

16.

Salmonella enterica Serotype Typhi with nonclassical quinolone resistance phenotype.

Accou-Demartin M, Gaborieau V, Song Y, Roumagnac P, Marchou B, Achtman M, Weill FX.

Emerg Infect Dis. 2011 Jun;17(6):1091-4. doi: 10.3201/eid/1706.101242.

17.

The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy.

Parry CM, Vinh H, Chinh NT, Wain J, Campbell JI, Hien TT, Farrar JJ, Baker S.

PLoS Negl Trop Dis. 2011 Jun;5(6):e1163. doi: 10.1371/journal.pntd.0001163. Epub 2011 Jun 21.

18.

Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern Tanzania.

Crump JA, Ramadhani HO, Morrissey AB, Msuya LJ, Yang LY, Chow SC, Morpeth SC, Reyburn H, Njau BN, Shaw AV, Diefenthal HC, Bartlett JA, Shao JF, Schimana W, Cunningham CK, Kinabo GD.

Trop Med Int Health. 2011 Jul;16(7):830-7. doi: 10.1111/j.1365-3156.2011.02774.x. Epub 2011 Apr 7.

19.

Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the midwestern region of the Republic of Ireland due to mutations in the gyrA gene.

Ryan MP, Dillon C, Adley CC.

J Clin Microbiol. 2011 May;49(5):2077-9. doi: 10.1128/JCM.02574-10. Epub 2011 Mar 9. No abstract available.

20.

Salmonella enterica serotype Virchow associated with human infections in Switzerland: 2004-2009.

Bonalli M, Stephan R, Käppeli U, Cernela N, Adank L, Hächler H.

BMC Infect Dis. 2011 Feb 23;11:49. doi: 10.1186/1471-2334-11-49.

Supplemental Content

Support Center